Introduction
============

The assembly of striated muscle myofibrils is a complex process in which numerous structural and regulatory proteins are assembled into basic contractile units, the sarcomeres ([@bib47]). The formation of sarcomeres requires the assembly of thin and thick filaments of appropriate length and their precise organization into higher order structures ([@bib21]). The highly organized sarcomeres effectively translate the molecular movements of myosin motors into macroscopic contraction of muscle fibers.

The mechanism by which thick filaments attain precise regularity in striated muscle remains unknown. Although previous studies demonstrated that myosin possesses self-assembly ability ([@bib30]), myosin filaments formed in vitro lack important features of in vivo thick filaments. Accumulating evidence suggests that the assembly of myosin into thick filaments of distinct lengths, diameters, and flexural rigidities requires the presence of other proteins ([@bib60]). In vertebrate muscles, several additional proteins are associated with thick filaments: C-protein, H-protein (mammals) or 86-kD protein (birds), M-protein, myomesin, M-creatine kinase, skelemin, adenosine monophosphate deaminase, and titin ([@bib21]; [@bib3]). Analogues of some of these proteins exist in invertebrates. For instance, in *Drosophila melanogaster*, three members of the titin family have been identified: projectin ([@bib2]), kettin ([@bib28]; [@bib33]), and D-titin ([@bib37]; [@bib59]).

Some proteins are unique to thick filaments of invertebrate striated muscles. For instance, *D. melanogaster* possesses paramyosin ([@bib58]; [@bib10]; [@bib40]), miniparamyosin ([@bib10]; [@bib40], [@bib41]), myosin rod protein ([@bib55]), and flightin ([@bib57]; [@bib50]). *Caenorhabditis elegans* has paramyosin ([@bib38]; [@bib31]) and α-, β-, and γ-filagenin ([@bib35], [@bib36]). The diversity of thick filament components may account for the highly variable lengths and diameters of muscle thick filaments from different species.

Paramyosin and myosin are the most abundant invertebrate thick filament proteins. Paramyosin is present in all invertebrate muscles studied ([@bib40]). This protein is a rodlike molecule with high α-helical content in its long central domain. This domain is flanked by short nonhelical NH~2~- and COOH-terminal regions. Two paramyosin monomers can dimerize into a coiled coil. Analysis of paramyosin and myosin heavy chain rod sequences revealed a remarkable pattern of alternating concentrations of charge associated with a 28-residue repeat ([@bib16]). Interactions between these segments of opposite charge are thought to play a major role in the assembly of both of these proteins into the thick filaments ([@bib42]; [@bib31]).

*Drosophila* paramyosin is a protein comprised of 879 amino acid residues with a molecular mass of ∼105 kD. The central 823 residues form an α helix; this is flanked by nonhelical domains of 32 NH~2~-terminal and 24 COOH-terminal residues ([@bib10]; [@bib40]). By using an alternative promoter and alternative RNA splicing, the paramyosin gene produces a transcript encoding miniparamyosin. Miniparamyosin shares its COOH-terminal region with paramyosin and has a unique NH~2~-terminal domain of 114 amino acids ([@bib10]; [@bib40]). Paramyosin is present in both embryonic and adult muscles. However, miniparamyosin is only present in adult musculature ([@bib41]).

Paramyosin is thought to facilitate thick filament assembly. Mutant analysis in *C. elegans* shows that thick filament length and diameter are affected by paramyosin content ([@bib38]). Based on biochemical, genetic, and structural studies of *C. elegans* thick filaments, [@bib24] proposed a thick filament structure model in *C. elegans*. In this model, paramyosin, together with the filagenins, forms the tubular thick filament core in which seven paramyosin subfilaments are interconnected by an internal sleeve of filagenins. Each paramyosin subfilament contains four strands of paramyosin coiled coils throughout its length. The motor protein myosin attaches on the surface of the core, yielding the functional thick filament ([@bib24]; [@bib44]). Notably, no homologues of *C. elegans* filagenins have been identified in *D. melanogaster* and miniparamyosin and flightin do not exist in *C. elegans*. Thus, the process of thick filament assembly in different organisms and the molecular mechanism involved in the formation of different types of myofibrils in each organism remain to be clarified.

To investigate the function of *D. melanogaster* paramyosin, we used a genetic approach. We functionally disabled the paramyosin gene by mobilizing a *P* element in its promoter region. We observed that homozygous paramyosin mutants die as late embryos and that myofibril assembly is disrupted. Surprisingly, we found that paramyosin is also required for myoblast fusion. In the absence of paramyosin, myoblast fusion is sometimes blocked, resulting in the absence of some muscle fibers. We rescued the homozygous paramyosin mutant to adulthood using a paramyosin transgene, thereby proving that defects observed in myoblast fusion and myofibril assembly arise specifically from the absence of paramyosin. Antibody localization confirmed that paramyosin is present in myoblasts before fusion and is localized in discrete foci at the contact sites of fusing myoblasts. Our results demonstrate that paramyosin functions as a cytoplasmic protein in early embryonic development and is important for myoblast fusion before its assembly into thick filaments.

Results
=======

Generation and identification of paramyosin mutants
---------------------------------------------------

A *P* element insertion is present in the paramyosin promoter region of fly line *prm*^106-5^ ([Fig. 1](#fig1){ref-type="fig"}). We identified this insertion line in screen for mutants with gross defects in neuromuscular function. To this end, we screened a collection of *P* element insertion mutants ([@bib18]) for gross defects in the motility that normally occurs in late embryos in the few hours before hatching. This line lacked normal peristaltic body wall movements and appeared to have uncontracted muscles. Sequencing of an inverse PCR product showed an insertion at coordinates 8703958-8703965 of the 3L scaffold sequence, or at nucleotides 59-66 of cDNA clone GH14085, which encodes paramyosin (genome and clone data available from Berkeley *Drosophila* Genome Project, <http://www.fruitfly.org/>). The insertion is located 174 bp upstream of the translation start site. The mutation failed to complement deficiency *Df(3L)h*^i22^, consistent with a mutation at cytogenetic location 66D10; 66E1--2, and with the location of the paramyosin gene at 66D12-66D14 (for cytological data, see FlyBase, <http://flybase.bio.indiana.edu:82/>). The insertion of a *P* element in this line reduces paramyosin expression to 70% of normal and homozygous mutants die at the first instar larval stage.

![**Paramyosin/miniparamyosin gene structure and its localization in the genome.** The *Drosophila* paramyosin/miniparamyosin gene is located on the left arm of the third chromosome, in region 66D12--66D14 and is shown with its 3′ end at the left to illustrate its orientation on the chromosome. The same locus in the *Drosophila* genome produces paramyosin and miniparamyosin by using different promoters and alternative splicing of exons. Paramyosin uses an upstream promoter and exons 1--9. Miniparamyosin is produced by use of an alternative promoter and an exon in intron 7, which is joined to the last two exons of the paramyosin transcript upon RNA splicing. In *Drosophila* line *prm*^106-5^, a *P* element is inserted in the 5′ end of the paramyosin gene, 174 bp upstream of the translation start site.](200208180f1){#fig1}

To make null or strongly hypomorphic alleles of the paramyosin gene, we mobilized the *P* element out of the locus by crossing male flies to female flies that produce *P* element transposase, hoping to mutate the flanking paramyosin gene by imprecise *P* element excision. From 140 crosses, 70 homozygous lethal lines were obtained. Most of these are embryonic lethal and others die at the first instar larval stage. 40 of the mutants can be rescued to adulthood with the wild-type paramyosin transgene pm ([@bib39]), indicating that they are paramyosin-specific mutants.

We used a paramyosin-specific antibody to determine paramyosin expression levels in the lines that could be rescued by the paramyosin transgene. We identified one strongly hypomorphic mutant in which the paramyosin expression level is \<1% ([Fig. 2](#fig2){ref-type="fig"} A). We refer to this line as *prm*^1^. Homozygous *prm*^1^ mutants die at the late embryo stage and are rescued to adulthood by the pm transgene.

![**Paramyosin and miniparamyosin expression in *prm*^1^ and rescued flies.** Protein extracts from stage 17 embryos (A) or adult upper thoraces (B) were separated by 10% SDS-PAGE, transferred to nitrocellulose membrane, and detected with paramyosin and miniparamyosin antibodies. (A) Homozygous paramyosin mutant *prm*^1^ is embryonic lethal and paramyosin expression in *prm*^1^ is reduced to 1% of wild-type level. (B) Paramyosin expression in rescued adult flies is restored to normal levels. Mutation of paramyosin in *prm*^1^ does not affect miniparamyosin expression (PM, paramyosin; mPM, miniparamyosin; *yw*, yellow white control flies; pm; *prm*^1^, homozygous *prm*^1^ rescued with the paramyosin transgene pm).](200208180f2){#fig2}

To determine the genetic lesion in the paramyosin gene of *prm*^1^, we isolated genomic DNA from homozygous *prm*^1^ embryos and used it as a template for PCR analysis along with paramyosin-specific primers. We then cloned PCR products into a plasmid vector and sequenced them. Sequence data showed that a 4-kb fragment 5′ to the second nucleotide of the transcription start site of the paramyosin gene is removed by imprecise excision in this line. This region contains one MEF-2 site and 3 E-boxes, and is important for paramyosin expression in larval and adult stages ([@bib1]). This result, together with the paramyosin expression and transgene rescue data, indicates that *prm*^1^ is a strong hypomorphic or functional null allele of the paramyosin gene.

The mutation in *prm*^1^ is paramyosin-specific
-----------------------------------------------

Because paramyosin and miniparamyosin are encoded at the same locus ([Fig. 1](#fig1){ref-type="fig"}), we wondered if the mutation of the paramyosin promoter region affects miniparamyosin expression. Expression of paramyosin and miniparamyosin in pm-transgene--rescued flies was analyzed by Western blotting using paramyosin and miniparamyosin antibodies. Results showed that both paramyosin and miniparamyosin expression in rescued flies are normal ([Fig. 2](#fig2){ref-type="fig"} B). Because the transgene used in rescue does not contain the miniparamyosin-specific exon, all the miniparamyosin expressed in rescued adult flies must be encoded by the endogenous miniparamyosin locus. This indicates that miniparamyosin expression is not affected by the deletion in the paramyosin promoter region caused by imprecise *P* element excision.

The deletion in *prm*^1^ uncovers a portion of the 284-bp CG13306, an open reading frame for which no cDNAs have been reported ([Fig. 1](#fig1){ref-type="fig"}). Deletion of CG13306 is not the cause of the mutant phenotypes we document because homozygous *prm*^1^ mutants could be rescued with the pm transgene (see Results), which is truncated within the CG13306 open reading frame.

Mutation of the paramyosin gene severely affects muscle development
-------------------------------------------------------------------

Homozygous *prm*^1^ embryos display grossly normal morphology including normal segmentation and epidermal denticle belts (unpublished data), but they fail to hatch at late embryonic stage 17. Compared with normal embryos, manually hatched late stage 17 *prm*^1^ homozygous embryos are flat and motionless, suggesting possible muscle defects.

We investigated the muscle development of homozygous *prm*^1^ embryos by staining muscle fibers of late stage 16 embryos with muscle myosin heavy chain antibody ([Fig. 3](#fig3){ref-type="fig"}). At this stage, the process of body wall muscle development is complete and each of the abdominal hemisegments (A2-A7) has 30 muscles ([@bib7]). Each of these muscles is unique in terms of its position, size, sites of attachment, and patterns of innervation. Every muscle has a full complement of nuclei, which remains unchanged until the end of larval life ([@bib6], [@bib7]). In *prm*^1^ mutant embryos, the regular muscle pattern is disrupted. At stage 16, over 95% of the mutant embryos have obviously detectable muscle losses and aberrantly shaped muscle fibers. Compared with wild-type counterparts, these aberrant fibers are shorter or thinner and have fewer nuclei (unpublished data). Muscle fiber absence in mutant embryos usually occurs in groups. It can take place at any position in the embryo, in all three major muscle subtypes: dorsal, lateral, and ventral. In embryos in which muscle development is severely disrupted, we observed an absence of several muscle groups in different segments of the same embryo. However, muscles that successfully developed are located in normal positions. We never observed cross-segment fibers or duplicated fibers. The mutant phenotype of muscle fiber losses in *prm*^1^ is confirmed in homozygotes for the deficiency *Df(3L)h*^i22^ki, which covers the paramyosin gene (unpublished data). The muscle fiber phenotype in the deficiency line is slightly worse than in *prm*^1^, reflecting leaky expression of paramyosin in *prm*^1^.

![**Embryo body wall muscle development is disrupted in homozygous** *prm***^1^ mutants.** Stage 16 *prm*^1^ embryos rescued by the paramyosin transgene (A--C) and homozygous *prm*^1^ embryos (D--F) were stained with muscle myosin antibody and visualized with confocal microscopy. (A) Dorsal lateral view of rescued embryo showing regular pattern of muscle fibers in each segment. (B and C) High magnification view of lateral (B) and ventral muscle groups (C) in rescued embryos. Arrows in B highlight lateral transverse muscles 21--24. (D) Dorsal lateral view of *prm*^1^ embryo; arrows highlight locations of missing fibers in this embryo. (E) High magnification view of lateral muscle group of a *prm*^1^ embryo. Note the presence of lateral transverse muscles (arrows) in the middle segment and the absence of their counterparts as well as other muscles in adjacent segments. (F) High magnification view of a portion of D showing the presence of free myoblasts in locations where muscle fibers are missing (arrows).](200208180f3){#fig3}

The loss of muscle fibers in *prm*^1^ embryos could arise from defects in the specification of myoblasts, from failure of founder cells and fusion-competent cells to fuse, or perhaps from defects in the attachment of muscle fibers to the epidermis. To assess the specification of founder cells, we created a fly strain in which the enhancer trap rP298-lacZ (which marks all founders of the embryonic musculature; [@bib45]) is expressed in *prm*^1^. Staining of rP298-lacZ; *prm*^1^ embryos with β-galactosidase antibody before myoblast fusion revealed that founder cells are normally specified in *prm*^1^ ([Fig. 4](#fig4){ref-type="fig"}, compare A with D). We examined the specification of all myoblasts by staining early embryos with DMEF2 antibody, which marks all somatic, visceral, and cardiac myoblasts ([@bib34]). The number of DMEF2 expressing cells in *prm*^1^ mutant embryos ([Fig. 4](#fig4){ref-type="fig"} E) was comparable to that in wild-type embryos ([Fig. 4](#fig4){ref-type="fig"} B). These data suggest that the initial differentiation of myoblasts in *prm*^1^ is normal. We also stained rP298-lacZ; *prm*^1^ embryos with β-galactosidase antibody and muscle myosin antibody to visualize founder cells and newly formed muscle fibers. We observed that unfused founder cells are present at the location of missing muscle fibers in *prm*^1^ ([Fig. 4](#fig4){ref-type="fig"} F). Finally, the expression pattern of paramyosin suggests that it is not likely to regulate fiber attachment to the epidermis. Expression in epidermis declines dramatically during myoblast fusion and eventually disappears after fiber formation; furthermore, paramyosin is not enriched at the ends of newly formed muscle fibers (see next section). These observations, in addition to the localization of paramyosin to sites of myoblast fusion (see next section), indicate that the loss of muscle fibers in *prm*^1^ mutant is due to defects in myoblast fusion.

![**Differentiation of mesodermal derivatives in wild-type and mutant embryos.** Wild-type (A--C) and *prm*^1^ mutant embryos (D--F) were stained with anti--β-galactosidase to detect founder cells labeled by enhancer trap rP298-lacZ on the X chromosome (A and D), anti-DMEF2 to detect all myoblasts (B and E), or double stained with anti--β-galactosidase and anti--muscle myosin antibodies (C and F). Lateral view of late stage 12 wild-type (A) and *prm*^1^ (D) embryos, showing founder cell locations. These are identical in normal and the *prm*^1^ embryo population (note that focus in D is shallower than in A). (B and E) Anti-DMEF2 staining of late stage 13 embryos confirms normal differentiation of myoblasts in mutant embryos. (C and F) Lateral view of stage 16 wild-type and mutant embryos labeled with anti--β-galactosidase (green) and anti--muscle myosin (red) antibodies. Insets show enlarged views of the region indicated by asterisk in F. Note the presence of unfused founder cells (arrows) in place of a missing muscle fiber (top inset). Myosin expression levels in these unfused founder cells is low (bottom inset).](200208180f4){#fig4}

Paramyosin is a cytoplasmic protein before myofibrillogenesis
-------------------------------------------------------------

The involvement of paramyosin in myoblast fusion indicates that it has functions in addition to serving as a thick filament protein in myofibrils. Based on its structural properties, paramyosin might be a component of the cytoskeleton before myofibrillogenesis. We stained wild-type *Drosophila* embryos of different stages with a paramyosin antibody and observed that paramyosin is localized in the cytoplasm at very early stages ([Fig. 5, A and B](#fig5){ref-type="fig"}). Before gastrulation occurs, paramyosin antibody stains the apical surface, lateral interface, and the basal opening of the syncytial blastoderm. Note that an embryo that is homozygous for a paramyosin mutation would not be expected to display a mutant phenotype at the blastoderm stage, since transcripts expressed at this stage are maternally inherited. During gastrulation, paramyosin expression levels decline, but weak staining is present in both the mesoderm and ectoderm ([Fig. 5, C and D](#fig5){ref-type="fig"}). At stage 12, paramyosin expression increases, with higher expression levels in somatic mesodermal cells ([Fig. 5](#fig5){ref-type="fig"} E). By stage 14, when most myoblast fusions occur ([@bib14]), paramyosin expression increases dramatically in fusing muscle fibers of somatic and pharyngeal muscles ([Fig. 5](#fig5){ref-type="fig"} F). Later in development, paramyosin disappears in the epidermis and is only detected in mesodermal derivatives, including body wall musculature, visceral musculature, and the heart. Previous Western blotting analysis ([@bib58]) is consistent with our antibody staining data ([Fig. 5](#fig5){ref-type="fig"}). [@bib58] reported that paramyosin is present in relatively high amounts in the cytoskeletal pellet of mature oocytes. Its levels are very low or undetectable during gastrulation, and increase progressively during middle and late embryogenesis. The presence of paramyosin in oocytes and in embryos before myofibrillogenesis strongly suggests a role as a general cytoskeleton protein.

![**Expression pattern of paramyosin in developing *Drosophila* embryos.** Wild-type embryos of different ages are stained with paramyosin antibody and visualized with confocal microscopy. (A and B) Syncytial blastoderm embryos showing high expression of paramyosin in the cortex. (C and D) Lateral view of stage 9 embryo (C) and stage 10 embryo (D). Note the decline of paramyosin expression level at these two stages. (E) Lateral view of late stage 12 embryo showing an increase of paramyosin expression and higher paramyosin levels in somatic mesodermal cells (arrows). (F) Lateral view of late stage 14 embryo showing higher expression level of paramyosin in newly formed somatic muscle and pharyngeal muscle (arrows). (G) Dorsal view of stage 15 embryo. Arrows show high levels of paramyosin in somatic and pharyngeal muscles. (H) Lateral view of stage 16 embryo. At this stage, paramyosin is not detected in the epidermis.](200208180f5){#fig5}

Because paramyosin has very high affinity to muscle myosin in myofibrils and in in vitro analysis ([@bib22]; [@bib60]), it is possible that paramyosin also interacts with myosin at early stages of development. We observed that both muscle myosin and nonmuscle myosin II are present in myoblasts, but their localization patterns are different ([Fig. 6](#fig6){ref-type="fig"}). Although both myosins are localized in the cytoplasm of unfused myoblasts or newly formed myotubes, nonmuscle myosin II is more enriched in discrete foci at the interface of fusing myoblasts in a manner similar to paramyosin. The involvement of nonmuscle myosin II in muscle fiber formation and later in myofibrillogenesis ([@bib11]) further suggests that these two proteins interact at this stage.

![**Staining of fusing** *Drosophila* **myoblasts with muscle myosin, nonmuscle myosin II, and paramyosin antibodies.** In fusing myoblasts, both muscle myosin (A) and nonmuscle myosin II (B) are present but have different localization patterns. Nonmuscle myosin is enriched in discrete foci at the contacting sites of fusing myoblasts (B, arrows), similar to paramyosin (C, see arrows).](200208180f6){#fig6}

Paramyosin mutation abolishes the striation pattern of muscles
--------------------------------------------------------------

Because previous studies have shown that paramyosin is a thick filament protein, the *prm*^1^ paramyosin mutation should affect thick filament assembly and myofibril organization. We studied the subcellular distribution patterns of muscle proteins in somatic muscles of mutant and rescued embryos by staining the body wall muscle fibers with muscle myosin antibody and phalloidin to label myosin thick filaments and actin thin filaments, respectively. We observed that, as in the wild-type embryo (unpublished data), rescued embryo muscle fibers have a regular cross-striated myofibril banding pattern with myosin and actin labeling. However, the banding patterns of myosin and actin in the *prm*^1^ mutant embryonic body wall muscles is completely disrupted ([Fig. 7](#fig7){ref-type="fig"}). This indicates that a severe reduction in paramyosin disrupts myofibril protein assembly in sarcomeres.

![**Muscle striation pattern is disrupted in the paramyosin mutant** *prm*^1^**.** Body wall muscles of dissected embryos were stained with different markers. Top row stained with muscle myosin antibody; middle row stained with FITC-phalloidin to visualize actin; bottom row contains overlaps of top and middle rows. The left column (A--C) depicts muscles from rescued *prm*^1^ embryos, which show striated localization of these two proteins in sarcomeres, identical to that of wild type (not depicted). The right column (D--F) shows disrupted localization of myosin and actin filaments in homozygous paramyosin mutant *prm*^1^.](200208180f7){#fig7}

Paramyosin is required for thick filament assembly and myofibril organization
-----------------------------------------------------------------------------

We compared the ultrastructure of mutant and wild-type embryonic body wall muscles by transmission electron microscopy. Well-organized sarcomeres are formed in somatic muscle fibers of wild-type embryos in stage 17. In longitudinal sections, muscle fibers display parallel arrays of thick and thin myofilaments ([Fig. 8, A and B](#fig8){ref-type="fig"}). At the end of thin filaments, Z bodies align to form Z bands ([Fig. 8, A and B](#fig8){ref-type="fig"}) that mark myofibrils into regularly separated sarcomeres. In contrast, sarcomeres are severely disrupted in *prm*^1^ mutant embryos of the same age. Z bodies are poorly organized ([Fig. 8](#fig8){ref-type="fig"} C). The lengths of myofilaments are greatly reduced and bundles of myofilaments associated with these Z bodies are not parallel ([Fig. 8](#fig8){ref-type="fig"} C). Similar defects were seen in other paramyosin mutants ([@bib39]). The observed mutant phenotype is consistent with that of a myosin heavy chain mutant, in which organization of Z bodies in embryo somatic muscles is disrupted ([@bib46]). The ultrastructural defects at the electron microscopic level explain the resulting loss of myofibril striation at the light microscopic level ([Fig. 7](#fig7){ref-type="fig"}).

![**Electron microscopy of wild-type and homozygous** *prm*^1^ **embryonic body wall muscles.** Thick and thin filaments in embryonic body wall muscles of wild-type embryos are well organized. In longitudinal sections (A and B), thick and thin filaments are parallel and arrange into smooth filament bundles. Z-bodies align to form Z-bands (A and B, arrows), which mark the myofibrils into sarcomeres. In a cross section (D), each thick filament is composed of several dense particles and they are arranged into a circular entity (arrowheads). Thick and thin filaments are organized into regular arrays. Mutation of paramyosin in *prm*^1^ causes a reduction in thick filament number and disrupts myofibril organization (C and E). *prm*^1^ myofibrils are shorter and wavy (C). Z-band material is poorly organized (C, arrows). In areas where thick filaments are formed, they are structurally abnormal. Dense particles in a cross section of thick filaments are no longer organized into circular, hollow structures (E, arrowheads). Bars: (A--C) 1 μm; (D and E) 0.1 μm.](200208180f8){#fig8}

Transverse sections of wild-type and *prm*^1^ mutant embryo myofibrils are shown in [Fig. 8](#fig8){ref-type="fig"} (D and E). Compared with wild-type embryos ([Fig. 8](#fig8){ref-type="fig"} D), *prm*^1^ mutant embryos have reduced thick filament numbers ([Fig. 8](#fig8){ref-type="fig"} E). However, thin filament number in the same area is relatively unaffected. This leads to some areas of myofibrils completely lacking thick filaments ([Fig. 8](#fig8){ref-type="fig"} E, arrows). Mutation of paramyosin also disrupted thick filament structure. Thick filaments from wild-type embryo body wall muscles are hollow ([Fig. 8](#fig8){ref-type="fig"} D, arrowheads). Each thick filament is circular in cross sections, consisting of several dense particles in the periphery. Compared with their wild-type counterparts, thick filaments of *prm*^1^ embryo body wall muscles are solid. Dense particles in the periphery collapse into the center, forming filled thick filaments ([Fig. 8](#fig8){ref-type="fig"} E, arrowheads). The diameters of thick filaments are also not even. We conclude that the paramyosin mutation reduces both the number and integrity of thick filaments.

Rescue of *prm*^1^ mutant phenotypes with the paramyosin transgene
------------------------------------------------------------------

To verify that the failure of myoblast fusion and aberrant myofibril assembly of somatic embryo body wall muscles in *prm*^1^ mutant embryos are indeed caused by the paramyosin mutation, we analyzed the muscle development and myofibril assembly of rescued embryos. The phenotypes observed in *prm*^1^ mutant embryos are restored to normal in rescued organisms. Rescued embryos have a normal embryonic body wall muscle pattern ([Fig. 3](#fig3){ref-type="fig"}, A--C). Each missing muscle fiber or group of fibers is restored and no duplicated or aberrant muscles are observed. The embryo body wall muscles of rescued embryos have a regular striation pattern of sarcomeres ([Fig. 7](#fig7){ref-type="fig"}).

As mentioned at the beginning of Results, the paramyosin transgene rescues the embryonic lethality of *prm*^1^. Homozygous *prm*^1^ survives to adulthood in the presence of the paramyosin transgene. Indirect flight muscles from rescued adult *prm*^1^ flies have normal myofibril structure ([Fig. 9](#fig9){ref-type="fig"}). In longitudinal sections, myofibrils have regular Z discs and M lines and sarcomere length is unchanged compared with wild type ([Fig. 9, A and B](#fig9){ref-type="fig"}). In transverse sections, thick and thin filaments are packed in a hexagonal manner and all the thick filaments have hollow centers ([Fig. 9](#fig9){ref-type="fig"}, C--F). This suggests that paramyosin expressed from the transgene is correctly assembled into thick filaments and that this further restored the assembly of myofibrils during myofibrillogenesis.

![**Ultrastructure of indirect flight muscle myofibrils in adult wild-type flies and homozygous** *prm*^1^ **rescued with the paramyosin transgene.** Compared with wild-type (*yw*) flies (A, C, and D), homozygous *prm*^1^ rescued with the paramyosin transgene (pm) has normal indirect flight muscle myofibril structure (B, E, and F). In longitudinal sections (A and B), thick and thin filaments assemble into regular sarcomeres and there is no difference in sarcomere length between wild-type and rescued fly myofibrils. In cross sections (C--F), thick filaments are hollow and are packed into a hexagonal array with thin filaments, typical of insect flight muscle structure. Bars, 0.5 μm.](200208180f9){#fig9}

Together, the data presented here indicate that paramyosin has dual functions at different stages of *Drosophila* myogenesis. Initially, paramyosin functions as a cytoplasmic protein that plays an important role in the processes of myoblast fusion. After myoblast fusion, paramyosin assists the assembly of muscle myosin molecules into well-organized thick filaments, which are capable of assembling into myofibrillar arrays.

Discussion
==========

Myogenesis is a process in which cells acquire numerous characteristics. Morphological changes that accompany myogenesis include fusions of myoblasts into multinucleate myotubes and the formation of the contractile apparatus ([@bib12]). Myoblast fusion consists of cell differentiation, cell--cell recognition, alignment, and membrane fusion ([@bib19]). Myoblast fusion precedes contractile apparatus formation. Elaboration of the contractile apparatus requires precise assembly of numerous structural and regulatory proteins into sarcomeres. In developing embryos of *Drosophila*, no myofibrils are assembled in unfused myoblasts and these myoblasts eventually are degraded and cleared by macrophages ([@bib53]). In this paper, we showed that paramyosin, a component of thick filaments, is not only involved in thick filament formation and myofibril assembly but also is important for myoblast fusion.

The role of paramyosin in myoblast fusion
-----------------------------------------

The events surrounding myoblast fusion in *D. melanogaster* have been studied extensively ([@bib49]; [@bib56]). Fusion always takes place between founders and fusion-competent myoblasts. An individual founder fuses with fusion-competent myoblasts to form muscle precursors with two or three nuclei. These precursors enlarge by recruiting and fusing with additional fusion-competent myoblasts to form multinucleate myotubes.

The most apparent mesodermal defect in embryos mutant for the paramyosin gene is random loss of muscle fibers or muscle fibers in aberrant shapes ([Fig. 3](#fig3){ref-type="fig"}). However, the defect in muscle development is not caused by reduction in myoblast number in early development ([Fig. 4](#fig4){ref-type="fig"}). Unfused myoblasts are present in the locations of missing muscles before being degraded ([Fig. 4](#fig4){ref-type="fig"} F), suggesting a role of paramyosin in the progression of cells from myoblasts to myotubes.

The structural features of paramyosin and its cytoplasmic location seem inconsistent with a role in cell adhesion, instead suggesting paramyosin functions as a cytoskeleton protein in early embryonic stages before myofibril formation. Paramyosin molecules form rodlike coiled-coil α-helical dimers that lack domains reminiscent of cell adhesion molecules. Furthermore, paramyosin is localized beneath the cell membrane of mesodermal cells and epidermal cells ([Fig. 6](#fig6){ref-type="fig"}). Paramyosin might attach the cytoskeleton to membrane adhesion sites, akin to the role of coiled-coil intermediate filaments in other organisms. This function might arise due to the lack of cytoplasmic intermediate filament proteins in *Drosophila* ([@bib27]).

As is the case for paramyosin, there are several other cytoplasmic proteins that are important for *Drosophila* myoblast fusion ([@bib49]; [@bib56]). These include the myofibrillar protein D-titin ([@bib59]), Blown fuse ([@bib19]), and Myoblast city ([@bib53]; [@bib19]; [@bib25]), found in both founders and fusion-competent myoblasts, as well as Rolling pebbles (Rols)/Antisocial (Ants) present only in founders ([@bib15]; [@bib43]). It is suggested that Rols/Ants functions as an intracellular adaptor protein that relays signals from the immunoglobulin family membrane protein Dumbfounded ([@bib52]) to the cytoskeleton during myoblast fusion ([@bib15]; [@bib43]).

The presence of the myofibrillar protein D-titin in developing myoblasts implicates cytoskeletal components in the process of myoblast fusion ([@bib59]). Defects in myoblast fusion similar to those in *prm*^1^ occur in *Drosophila* D-titin mutants. Compared with wild-type muscles, embryo body wall muscles of D-titin mutants are smaller and thinner. Occasionally, a few missing muscles are observed in severe mutant alleles ([@bib59]). The motor protein nonmuscle myosin II is also important for muscle fiber formation in *Drosophila* embryos ([@bib11]). In *zipper* mutants of nonmuscle myosin II, some ventral muscles are deleted. The involvement of D-titin and possible involvement of nonmuscle myosin II in myoblast fusion support the hypothesis that contractile elements play a role in this process. Later, we discuss a model in which paramyosin serves as part of nonmuscle myosin minifilaments that interact with the actin cytoskeleton to regulate cortical cytoskeleton dynamics and promote myoblast fusion.

The role of paramyosin in thick filament formation and myofibril assembly
-------------------------------------------------------------------------

Accumulating evidence suggests that the assembly of muscle myosin into thick filaments requires the presence of other proteins ([@bib3]). Biochemical, cell biological, and genetic studies in invertebrates support this hypothesis. In *D. melanogaster*, paramyosin, miniparamyosin, myosin rod protein, and flightin are all present in the A band region of some muscle sarcomeres ([@bib57]; [@bib41]; [@bib55]). Flightin knockout flies show increased thick filament length in indirect flight muscles, suggesting that flightin regulates thick filament assembly ([@bib50]). In *C. elegans*, the thick filament protein UNC-45 acts as a myosin chaperone ([@bib5]) and *unc-45* mutations disrupt thick filament assembly ([@bib4]). *C. elegans\'* thick filament cores contain paramyosin and three filagenins ([@bib35]). Mutation of paramyosin in *C. elegans* greatly reduces the length of thick filaments and disrupts the distribution of myosin isoforms ([@bib38]; [@bib23]).

Consistent with the *C. elegans* studies, we found that the body wall muscles of homozygous *prm*^1^ embryos have a marked reduction in the number of observable thick filaments, resulting in areas containing only thin filaments. Two factors might contribute to the formation of thick filaments in this line. The paramyosin from leaky expression of *prm*^1^ may interact with other unidentified thick filament core proteins, nucleating myosin molecules into these abnormal thick filaments. Alternatively, myosin may directly interact with these unidentified proteins to form abnormal thick filaments. We conclude that paramyosin is important for the production of an adequate number of morphologically normal thick filaments.

Another specific characteristic of *prm*^1^ is that the striated pattern of embryonic body wall muscles is disrupted. Although thin filaments assemble in the absence of paramyosin, they could not organize into regular sarcomeric patterns. The localization of paramyosin in thick filaments does not support a role as a scaffold in organizing myofibrils. Thus, abnormal interaction of thin and thick filaments might be the direct cause of this phenotype. Mutations in other *Drosophila* muscle contractile proteins also disrupt sarcomere organization, including actin ([@bib54]), troponin-T ([@bib26]), troponin-I ([@bib8]), myosin heavy chain ([@bib46]; [@bib9]), and α-actinin ([@bib51]). This indicates that correct interaction between thin and thick filaments is required for myofibril formation.

A model of paramyosin function in *Drosophila* muscle differentiation
---------------------------------------------------------------------

The formation of myofibrils has been extensively studied in embryonic vertebrate cardiac and skeletal muscle cells and several models have been proposed. In cultured cardiomyocytes, Sanger and colleagues ([@bib17]) suggested that premyofibrils, characterized by banded patterns of α-actinin--rich Z-bodies and nonmuscle myosin IIB, form at the edges of spreading cardiomyocytes and develop into mature myofibrils. During the transition from premyofibrils to myofibrils, there is an exchange of nonmuscle myosin IIB filaments for muscle myosin II filaments and a growth and fusion of Z-bodies into Z-bands. Evidence from developing chicken embryo hearts ([@bib20]) did not substantiate the presence of premyofibrils in vivo*.* An alternative model, based on observations of cultured cardiomyocytes, proposes that spatially separate complexes of actin filaments and Z-bands (I--Z--I brushes) and groups of myosin thick filaments assemble independently of one another; they become spliced together by titin filaments, and then inserted at the ends of fully formed myofibrils ([@bib48]). Although these models differ in detailed steps of myofibril formation, they agree that myofibrillogenesis starts with membrane association and that thick and thin filaments form independently. According to these previous studies and our evidence of paramyosin\'s dual roles in myoblasts and myofibrils, we propose a model of paramyosin in *Drosophila* muscle differentiation.

The transition of paramyosin from a cytoplasmic location to myofibrils can be divided into several steps in our model. First, before myoblast fusion, paramyosin binds to nonmuscle myosin filaments. These paramyosin-nucleated nonmuscle myosin filaments interact with filamentous actin in the cytoskeleton of myoblasts to regulate cell shape change and membrane penetration during cell fusion. Adaptor proteins, such as Rols/Ants, help keep these paramyosin nonmuscle myosin filaments in discrete foci at this stage. Second, after myoblast fusion, nonmuscle myosin is replaced by muscle myosin. Paramyosin, together with other thick filament core proteins, nucleate muscle myosin filaments into muscle thick filament precursors. Third, actin filaments and titin of I--Z--I brushes incorporate precursor thick filaments into A-bands of nascent myofibrils, as in cultured cardiomyocytes ([@bib17]; [@bib29]). Filaments may be first aligned out-of-register, and then transported into position. Finally, both thin and thick filaments elongate and myofibril diameter increases by peripheral addition of myofilaments.

Overall, our work revealed a role of paramyosin in thick filament formation and myofibrillogenesis. We also discovered that paramyosin has an unexpected function in myoblast fusion. Antibody localization and analysis of contractile protein mutants available in the *Drosophila* system will permit testing of our model of paramyosin function in muscle differentiation.

Materials and methods
=====================

Fly stocks
----------

Yellow white (*yw*) flies were used as a wild-type control line. Fly line *yw; 0106/05 \[P, w*^+^*\]/TM2, Ubx Sb* (referred to as *prm*^106-5^ hereafter) was recovered from an enhancer-trapping screen for genes essential for neuromuscular function (Results). Line *prm*^106-5^ was obtained from a third chromosome *P* element insert collection ([@bib18]) that had been balanced with a *TM6C*, *Sb*, *Hu* chromosome. In this line, a *P* element is inserted in the promoter region of the paramyosin gene, 174 bp upstream of the translation start site. Line rP298 is a P\[lacZ, *ry*^+^\] insertion line on the X chromosome ([@bib45]). We constructed fly line *yw; MKRS, Sb/TM3, y*^+^ *Ser*. The deficiency line *yw; Df(3L)h*^i22^ki /TM3, y^+^ *Ser* and transposase-producing line *w; Sp/CyO;* Δ*2--3, Sb/TM2, Ubx* were obtained from the Bloomington Stock Center.

Screening for late embryo motility defects
------------------------------------------

Embryos were collected for 1 h and aged to 22 h at 25°C, by which stage most wild-type embryos (including *TM6C* homozygotes) had hatched ([@bib13]). Unhatched embryos were dechorionated and observed for spontaneous peristaltic larval movement and tested for movement in response to touching by forceps. Mutant lines whose development appeared normal, but which were defective for larval movement, were rescreened to confirm the phenotype.

Genetic screen to isolate new paramyosin mutants
------------------------------------------------

To isolate new alleles of the paramyosin gene by imprecise *P* element excision, individual male *yw; prm*^106-5^/*TM2*, *Ubx Sb* flies were mated to virgin female *w; Sp/CyO;* Δ*2--3, Sb/TM2, Ubx* flies, which produce transposase. The *white*^+^ gene in the *P* element was used as a marker for *P* element mobilization. Individual male F1 *yw; prm*^106-5^/Δ*2--3, Sb* flies with blotchy eyes were selected and then mated to *yw; MKRS, Sb/TM3, y*^+^ *Ser* virgin female flies. Sibling white-eyed F2 *yw; prm*^106-5^/*TM3*, *y^+^ Ser* flies from each cross were mated to each other to make a stable stock for each mutant line. Lines in which *yw*; *prm*^106-5^/*prm^106-5^* flies could be recovered were probably progeny of flies with a precise *P* element excision and were discarded. Homozygous lethal lines likely contain new mutant alleles of the paramyosin gene and were kept for further analysis.

To identify paramyosin mutants, a paramyosin transgene *P\[w*^+^*, PM\]* (referred to as pm in the text) ([@bib39]) was crossed into these mutant backgrounds. Mutants that could be rescued to adulthood were considered to be paramyosin-specific mutants. Paramyosin-specific mutants, which are embryonic lethal, were used for paramyosin expression analysis. We used mouth hook color as a marker to differentiate homozygous mutant embryos from heterozygous embryos. Homozygous mutant embryos have yellow mouth hooks because they lack the balancer chromosome, which carries a black mouth hook marker (*y*^+^). Paramyosin expression levels were analyzed by Western blotting using antiparamyosin antibody ([@bib40]).

Protein electrophoresis and Western blotting
--------------------------------------------

Protein electrophoresis of dechorinated embryos or dissected adult upper thoraces and Western blotting with antiparamyosin and antiminiparamyosin antibodies were performed as described by [@bib40]. Antibody detection was performed using the SuperSignal system (Pierce Chemical Co.). The relative amounts of proteins were determined by scanning densitometry of bands on films (Expression 636 scanner \[Epson\]; NIH Image 1.61).

DNA analysis
------------

The insertion site of the *P* element in line *prm*^106--5^ was determined by inverse PCR and cycle sequencing, essentially as described by the Berkeley *Drosophila* Genome Project (<http://www.fruitfly.org/p_disrupt/inverse_pcr.html>). To determine the extent of the deletion resulting from imprecise *P* element excision, genomic DNA was extracted from *prm*^1^ embryos. 100 ng of DNA were used as template for PCR with the Roche Expand Long Template PCR system (Roche Biosciences). Primers used were: forward primer, 5′GTTTTTAGTTCTCGGTTCTTTTTGTTGGAC3′; and reverse primer, 5′AAAAAGTTGCCGATTGCCACAAAGGCCACG3′. PCR products were cloned and sequenced.

Immunohistochemistry
--------------------

Antibody staining of whole-mount embryos and of dissected embryos for confocal microscopy was performed as described ([@bib6]; [@bib53]). Antibodies used are: anti--muscle myosin and anti--nonmuscle myosin II antibodies ([@bib32]); antiparamyosin and antiminiparamyosin antibodies ([@bib40]); anti-DMEF2 ([@bib34]); mouse monoclonal anti--β-galactosidase antibody (Promega); Cy5-labeled goat anti--rabbit Ig (Amersham Biosciences); and goat anti--mouse Ig Alexa Fluor 488 conjugate (Molecular Probes). FITC-phalloidin was purchased from Molecular Probes.

Electron microscopy
-------------------

Electron microscopy of adult indirect flight muscles and embryos was done following previously published procedures ([@bib46]).
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